EXECUTIVE ENGAGEMENTS BY TIER
HIGHLIGHTS & REPORT INDEX
Global Drug-Eluting Stents Market to Reach US$11.7 Billion by 2030
The global market for Drug-Eluting Stents estimated at US$7.8 Billion in the year 2023, is expected to reach US$11.7 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Polymer-Free, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$7.9 Billion by the end of the analysis period. Growth in the Polymer-based segment is estimated at 5.3% CAGR over the analysis period.
The U.S. Market is Estimated at US$2.1 Billion While China is Forecast to Grow at 9.6% CAGR
The Drug-Eluting Stents market in the U.S. is estimated at US$2.1 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.6 Billion by the year 2030 trailing a CAGR of 9.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.0% and 6.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.
Global Drug-Eluting Stents Market - Key Trends and Drivers Summarized
What Are Drug-Eluting Stents and How Do They Function?
Drug-eluting stents (DES) are specialized medical devices used to treat coronary artery disease (CAD), a condition characterized by the narrowing of coronary arteries due to plaque buildup. These stents are tiny mesh tubes coated with medication that is gradually released to prevent the artery from becoming blocked again, a process known as restenosis. The structure of a drug-eluting stent includes a metal scaffold to provide mechanical support to the artery, and a polymer coating that controls the release of the drug over time. The drug inhibits cell proliferation and reduces inflammation, which are critical factors in preventing restenosis. By combining mechanical and pharmacological approaches, DES offer a significant improvement over bare-metal stents (BMS), which only provide structural support and are associated with higher rates of restenosis.
How Have Technological Advancements Improved Drug-Eluting Stents?
The field of drug-eluting stents has seen remarkable technological advancements that have enhanced their efficacy and safety profiles. Innovations in stent design, such as thinner struts and more flexible materials, have improved the deliverability and conformability of the stents, allowing for easier navigation through complex arterial pathways. The development of biodegradable polymers, which gradually dissolve after delivering the drug, has reduced long-term complications associated with permanent polymer residues. Advances in drug formulations have also played a crucial role, with newer drugs offering better control over cell proliferation and inflammation. Imaging technologies, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), have further refined the deployment process by providing real-time, high-resolution images of the arteries, ensuring precise placement and optimal expansion of the stents. These technological improvements collectively contribute to better patient outcomes, reducing the incidence of adverse events and the need for repeat interventions.
What Are the Clinical Applications and Benefits of Drug-Eluting Stents?
Drug-eluting stents are primarily used in the treatment of coronary artery disease, but their applications extend to other vascular conditions as well. They are employed in the management of peripheral artery disease (PAD), where they help to open narrowed arteries in the legs, enhancing blood flow and reducing symptoms like pain and fatigue. The use of DES in treating complex lesions, such as those in patients with diabetes or multivessel disease, has shown promising results, offering a safer and more effective alternative to surgical interventions. The primary benefits of DES include a lower risk of restenosis and reduced need for repeat revascularization procedures, leading to improved long-term patient outcomes. Additionally, the minimally invasive nature of stent implantation, combined with shorter hospital stays and faster recovery times compared to open-heart surgery, makes DES a preferred option for many patients and healthcare providers.
What Drives the Growth in the Drug-Eluting Stents Market?
The growth in the drug-eluting stents market is driven by several factors, including technological advancements, increasing prevalence of cardiovascular diseases, and expanding healthcare infrastructure. The rising incidence of coronary artery disease, partly due to lifestyle changes and an aging population, is significantly boosting the demand for effective treatment options like DES. Advances in stent technology, such as the development of next-generation stents with enhanced biocompatibility and drug delivery mechanisms, are propelling market growth. Additionally, the growing preference for minimally invasive procedures among patients and healthcare providers is driving the adoption of DES over traditional surgical methods. Regulatory approvals and favorable reimbursement policies are also playing a crucial role in expanding the market reach. Furthermore, increasing investments in research and development by key industry players and the expansion of healthcare facilities in emerging markets are creating new opportunities for growth. The integration of advanced imaging technologies with stent deployment procedures is improving clinical outcomes, further strengthening the case for DES in cardiovascular treatment protocols. These factors, combined with a greater awareness of heart health and proactive management of cardiovascular conditions, are driving the robust growth of the drug-eluting stents market.
SCOPE OF STUDY
The report analyzes the Drug-Eluting Stents market in terms of US$ Million by the following Application; Coating; End-Use, and Geographic Regions/Countries:
Segments:
Coating (Polymer-Free, Polymer-based); Application (Coronary Artery Disease, Peripheral Artery Disease); End-Use (Cardiology Centers, Ambulatory Surgery Centers, Hospitals).
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa..
SELECT PLAYERS
Abbott Laboratories; AlviMedica; Arterius Limited; Biotronik SE; Boston Scientific Corporation; Cook Medical; Medtronic plc ; STENTYS SA; Terumo Corporation
TABLE OF CONTENTS
I. METHODOLOGY |
II. EXECUTIVE SUMMARY |
1. MARKET OVERVIEW |
Influencer Market Insights |
Global Economic Update |
Drug-Eluting Stents – Global Key Competitors Percentage Market Share in 2024 (E) |
Competitive Market Presence - Strong/Active/Niche/Trivial for 33 Players Worldwide in 2024 (E) |
2. FOCUS ON SELECT PLAYERS |
3. MARKET TRENDS & DRIVERS |
Technological Advancements in Stent Design Propel Growth in Drug-Eluting Stents Market |
Increasing Prevalence of Cardiovascular Diseases Expands Addressable Market Opportunity |
Innovations in Biodegradable Polymers Strengthen Business Case for Next-Generation Stents |
Advances in Drug Formulations Enhance Efficacy and Reduce Complications |
Growing Geriatric Population Generates Increased Demand for Cardiovascular Treatments |
Trends in Personalized Medicine and Patient-Specific Solutions Propel Market Growth |
Expansion of Healthcare Infrastructure in Emerging Markets Creates New Opportunities |
Integration of Imaging Technologies and Stent Deployment Techniques Improves Outcomes |
Focus on Long-Term Patient Outcomes and Reduced Restenosis Rates Sustains Growth |
Adoption of Advanced Manufacturing Processes Enhances Stent Quality and Performance |
Development of Dual Therapy Stents and Combination Products Generates New Market Segments |
Impact of Lifestyle Changes and Risk Factors on Cardiovascular Health Drives Market Demand |
4. GLOBAL MARKET PERSPECTIVE |
World Drug-Eluting Stents Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030 |
World Recent Past, Current & Future Analysis for Drug-Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR |
World Historic Review for Drug-Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
World 16-Year Perspective for Drug-Eluting Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030 |
World Recent Past, Current & Future Analysis for Polymer-Free by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR |
World Historic Review for Polymer-Free by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
World 16-Year Perspective for Polymer-Free by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030 |
World Recent Past, Current & Future Analysis for Polymer-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR |
World Historic Review for Polymer-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
World 16-Year Perspective for Polymer-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030 |
World Recent Past, Current & Future Analysis for Coronary Artery Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR |
World Historic Review for Coronary Artery Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
World 16-Year Perspective for Coronary Artery Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030 |
World Recent Past, Current & Future Analysis for Peripheral Artery Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR |
World Historic Review for Peripheral Artery Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
World 16-Year Perspective for Peripheral Artery Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030 |
World Recent Past, Current & Future Analysis for Cardiology Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR |
World Historic Review for Cardiology Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
World 16-Year Perspective for Cardiology Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030 |
World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR |
World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030 |
World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR |
World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030 |
III. MARKET ANALYSIS |
UNITED STATES |
Drug-Eluting Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E) |
USA Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
USA Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
USA 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030 |
USA Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
USA Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
USA 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030 |
USA Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
USA Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
USA 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030 |
CANADA |
Canada Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Canada Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Canada 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030 |
Canada Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Canada Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Canada 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030 |
Canada Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Canada Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Canada 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030 |
JAPAN |
Drug-Eluting Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E) |
Japan Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Japan Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Japan 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030 |
Japan Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Japan Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Japan 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030 |
Japan Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Japan Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Japan 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030 |
CHINA |
Drug-Eluting Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E) |
China Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
China Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
China 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030 |
China Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
China Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
China 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030 |
China Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
China Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
China 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030 |
EUROPE |
Drug-Eluting Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E) |
Europe Recent Past, Current & Future Analysis for Drug-Eluting Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR |
Europe Historic Review for Drug-Eluting Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Europe 16-Year Perspective for Drug-Eluting Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030 |
Europe Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Europe Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Europe 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030 |
Europe Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Europe Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Europe 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030 |
Europe Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Europe Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Europe 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030 |
FRANCE |
Drug-Eluting Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E) |
France Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
France Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
France 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030 |
France Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
France Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
France 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030 |
France Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
France Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
France 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030 |
GERMANY |
Drug-Eluting Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E) |
Germany Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Germany Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Germany 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030 |
Germany Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Germany Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Germany 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030 |
Germany Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Germany Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Germany 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030 |
ITALY |
Italy Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Italy Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Italy 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030 |
Italy Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Italy Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Italy 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030 |
Italy Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Italy Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Italy 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030 |
UNITED KINGDOM |
Drug-Eluting Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E) |
UK Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
UK Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
UK 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030 |
UK Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
UK Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
UK 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030 |
UK Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
UK Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
UK 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030 |
SPAIN |
Spain Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Spain Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Spain 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030 |
Spain Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Spain Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Spain 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030 |
Spain Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Spain Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Spain 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030 |
RUSSIA |
Russia Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Russia Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Russia 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030 |
Russia Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Russia Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Russia 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030 |
Russia Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Russia Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Russia 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030 |
REST OF EUROPE |
Rest of Europe Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Rest of Europe Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Rest of Europe 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030 |
Rest of Europe Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Rest of Europe Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Rest of Europe 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030 |
Rest of Europe Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Rest of Europe Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Rest of Europe 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030 |
ASIA-PACIFIC |
Drug-Eluting Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E) |
Asia-Pacific Recent Past, Current & Future Analysis for Drug-Eluting Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR |
Asia-Pacific Historic Review for Drug-Eluting Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Asia-Pacific 16-Year Perspective for Drug-Eluting Stents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030 |
Asia-Pacific Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Asia-Pacific Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Asia-Pacific 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030 |
Asia-Pacific Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Asia-Pacific Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Asia-Pacific 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030 |
Asia-Pacific Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Asia-Pacific Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Asia-Pacific 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030 |
AUSTRALIA |
Drug-Eluting Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E) |
Australia Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Australia Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Australia 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030 |
Australia Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Australia Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Australia 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030 |
Australia Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Australia Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Australia 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030 |
INDIA |
Drug-Eluting Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E) |
India Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
India Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
India 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030 |
India Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
India Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
India 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030 |
India Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
India Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
India 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030 |
SOUTH KOREA |
South Korea Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
South Korea Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
South Korea 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030 |
South Korea Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
South Korea Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
South Korea 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030 |
South Korea Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
South Korea Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
South Korea 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030 |
REST OF ASIA-PACIFIC |
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Rest of Asia-Pacific Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Rest of Asia-Pacific 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030 |
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Rest of Asia-Pacific Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Rest of Asia-Pacific 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030 |
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Rest of Asia-Pacific Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Rest of Asia-Pacific 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030 |
LATIN AMERICA |
Drug-Eluting Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E) |
Latin America Recent Past, Current & Future Analysis for Drug-Eluting Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR |
Latin America Historic Review for Drug-Eluting Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Latin America 16-Year Perspective for Drug-Eluting Stents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030 |
Latin America Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Latin America Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Latin America 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030 |
Latin America Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Latin America Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Latin America 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030 |
Latin America Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Latin America Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Latin America 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030 |
ARGENTINA |
Argentina Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Argentina Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Argentina 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030 |
Argentina Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Argentina Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Argentina 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030 |
Argentina Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Argentina Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Argentina 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030 |
BRAZIL |
Brazil Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Brazil Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Brazil 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030 |
Brazil Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Brazil Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Brazil 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030 |
Brazil Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Brazil Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Brazil 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030 |
MEXICO |
Mexico Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Mexico Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Mexico 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030 |
Mexico Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Mexico Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Mexico 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030 |
Mexico Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Mexico Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Mexico 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030 |
REST OF LATIN AMERICA |
Rest of Latin America Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Rest of Latin America Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Rest of Latin America 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030 |
Rest of Latin America Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Rest of Latin America Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Rest of Latin America 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030 |
Rest of Latin America Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Rest of Latin America Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Rest of Latin America 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030 |
MIDDLE EAST |
Drug-Eluting Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E) |
Middle East Recent Past, Current & Future Analysis for Drug-Eluting Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR |
Middle East Historic Review for Drug-Eluting Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Middle East 16-Year Perspective for Drug-Eluting Stents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030 |
Middle East Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Middle East Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Middle East 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030 |
Middle East Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Middle East Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Middle East 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030 |
Middle East Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Middle East Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Middle East 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030 |
IRAN |
Iran Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Iran Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Iran 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030 |
Iran Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Iran Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Iran 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030 |
Iran Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Iran Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Iran 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030 |
ISRAEL |
Israel Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Israel Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Israel 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030 |
Israel Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Israel Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Israel 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030 |
Israel Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Israel Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Israel 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030 |
SAUDI ARABIA |
Saudi Arabia Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Saudi Arabia Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Saudi Arabia 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030 |
Saudi Arabia Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Saudi Arabia Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Saudi Arabia 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030 |
Saudi Arabia Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Saudi Arabia Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Saudi Arabia 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030 |
UNITED ARAB EMIRATES |
UAE Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
UAE Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
UAE 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030 |
UAE Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
UAE Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
UAE 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030 |
UAE Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
UAE Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
UAE 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030 |
REST OF MIDDLE EAST |
Rest of Middle East Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Rest of Middle East Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Rest of Middle East 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030 |
Rest of Middle East Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Rest of Middle East Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Rest of Middle East 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030 |
Rest of Middle East Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Rest of Middle East Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Rest of Middle East 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030 |
AFRICA |
Drug-Eluting Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E) |
Africa Recent Past, Current & Future Analysis for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Africa Historic Review for Drug-Eluting Stents by Coating - Polymer-Free and Polymer-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Africa 16-Year Perspective for Drug-Eluting Stents by Coating - Percentage Breakdown of Value Sales for Polymer-Free and Polymer-based for the Years 2014, 2024 & 2030 |
Africa Recent Past, Current & Future Analysis for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Africa Historic Review for Drug-Eluting Stents by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Africa 16-Year Perspective for Drug-Eluting Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2014, 2024 & 2030 |
Africa Recent Past, Current & Future Analysis for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR |
Africa Historic Review for Drug-Eluting Stents by End-Use - Cardiology Centers, Ambulatory Surgery Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR |
Africa 16-Year Perspective for Drug-Eluting Stents by End-Use - Percentage Breakdown of Value Sales for Cardiology Centers, Ambulatory Surgery Centers and Hospitals for the Years 2014, 2024 & 2030 |
IV. COMPETITION |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com